knowledge -WSS

knowledge

author：leisure time 2025-10-02 07:05:50 - browse：39

A young boy died in a trial for Pfizer’s experimental gene therapy for Duchenne muscular dystrophy, the company told patient advocates Tuesday.

The boy was enrolled in Daylight, a trial studying the treatment in boys aged 2 or 3. The boy had received the therapy early last year, Pfizer told the advocates in a note posted online by Parent Project Muscular Dystrophy.

Pfizer said the boy died of cardiac arrest, but that it was still working to understand what happened and the exact cause.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： How to pay for weight loss drugs and save Medicare

entertainment

WSS

Fetal surgery at risk from Dobbs and new abortion restrictions

Medicare has a new plan to address drug shortages

How dance can help nurses traumatized by Covid

Google and Epic fight stronger regulation of AI in health care

Group opposing PBM reform sets lobbying record

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

hotspot

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

knowledge

In Memoriam: Notable people who died in 2023

Organ aging and disease risk measured by new blood test

Dobbs anniversary: the lost opportunity of abortion as health care

Sanders adds drug shortage policies to pandemic preparedness bill

Dobbs anniversary: the lost opportunity of abortion as health care

At Orexo, a ‘turning point’ for everything but digital health

Hollywood unions extend contract negotiations for actors

30 years of 'Listening to Prozac'

State Dept. review finds Biden bears some blame for Afghanistan failures

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

hotspot

STAT Virtual Event: The State of Biosimilars: What to Watch

How dance can help nurses traumatized by Covid

Listen: Wegovy in the brain & pivotal Alzheimer's data

Will the market for weight loss drugs really reach $100 billion?

Pediatric cancer treatments threatened by a new FDA policy

Cosmetics set for new safety regulation. Why the industry is on board

focus

leisure time

entertainment

focus